Synthesis and evaluation of vancomycin aglycon analogues that bear modifications in the N-terminal D-leucyl amino acid

Journal of Medicinal Chemistry

Volumn 52, Issue 5, 2009, Pages 1471-1476

  Crane, Christine M ^a   Boger, Dale L ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGLYCONE; AMINE; AMINO ACID DERIVATIVE; HYDRAZINE DERIVATIVE; LIGAND; NUCLEOPHILE; VANCOMYCIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; CHEMICAL MODIFICATION; EVALUATION; HYDROGEN BOND; SYNTHESIS;

AMINES; ANTI-BACTERIAL AGENTS; ENTEROCOCCUS FAECALIS; HYDRAZINES; HYDROGEN BONDING; LEUCINE; LIGANDS; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; STAPHYLOCOCCUS AUREUS; STRUCTURE-ACTIVITY RELATIONSHIP; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 64349084025     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm801549b     Document Type: Article

References (42)

1. For reviews see the following: (a) Kahne, D.; Leimkuhler, C.; Lu, W.; Walsh, C. T. Glycopeptide and Lipoglycopeptide Antibiotics. Chem. Rev. 2005, 705, 428-448.
2. (b) Hubbard, B. K.; Walsh, C. T. Vancomycin Assembly: Nature's Way. AngewChem.,Int Ed. 2003, 42, 730-765.
3. Williams, D. H.; Bardsley, B. The Vancomycin Group of Antibiotics and the Fight against Resistant Bacteria. Angew. Chem., Int. Ed. 1999, 38, 1172-1193.
4. (d) Malabarba, A.; Nicas, T. I.; Thompson, R. C. Structural Modifications of Glycopeptide Antibiotics. Med. Res. Rev. 1997, 17, 69-137.
5. For reviews on glycopeptide resistance see the following: (a) Mala- barba, A.; Ciabatti, R. Glycopeptide Derivatives. Curr. Med. Chem. 2001, 8, 1759-1773.
6. (b) Pootoolal, J.; Neu, J.; Wright, G. D. Glycopeptide Antibiotic Resistance. Annu. Rev. Pharmacol. Toxicol. 2002, 42, 381-408.
7. (c) Van Bambeke, F. V.; Van Laethem, Y.; Courvalin, P.; Tulkens, P. M. Glycopeptide Antibiotics: From Conventional to New Derivatives. Drugs 2004, 64, 913-936.
8. (d) Siissmuth, R. D. Vancomycin Resistance: Small Molecule Approaches Targeting the Bacterial Cell Wall Biosynthesis. ChemBioChem 2002, 3, 295-298.
9. (e) Gao, Y. Glycopeptide Antibiotics and Development of Inhibitors to Overcome Vancomycin Resistance. Nat. Prod. Rep. 2002,19, 100-107.
10. (f) Healy, V. L.; Lessard, I. A.; Roper, D. I.; Knox, J. R.; Walsh, C. T. Vancomycin Resistance in Enterococci: Repro- gramming of the D-Ala-D-Ala Ligases in Bacterial Peptidoglycan Biosynthesis. Chem. Biol. 2000, 7, R109-R119.
11. McComas, C. C.; Crowley, B. M.; Boger, D. L. Partitioning the Loss in Vancomycin Binding Affinity for D-Ala-D-Lac into Lost H-Bond and Repulsive Lone Pair Contributions. J. Am. Chem. Soc. 2003, 125, 9314-9315.
12. 4]Vancomycin Aglycon: Reengineering Vancomycin for Dual D-Ala-D-Ala and D-Ala-D-Lac Binding. J. Am. Chem. Soc. 2006, 128, 2885-2892.
13. For related synthetic efforts, see the following: (b) Boger, D. L.; Miyazaki, S.; Kim, S. H.; Wu, J. H.; Loiseleur, O.; Castle, S. L. Diastereoselective Total Synthesis of the Vancomycin Aglycon with Ordered Atropisomer Equilibrations. J. Am.Chem. Soc. 1999, 121, 3226-3227.
14. (c) Boger, D. L.; Miyazaki, S.; Kim, S. H.; Wu, J. H.; Castle, S. L.; Loiseleur, O.; Jin, Q. Total Synthesis of the Vancomycin Aglycon. J. Am. Chem. Soc. 1999, 121, 10004-10011.
15. (d) Boger, D. L.; Kim, S. H.; Miyazaki, S.; Strittmatter, H.; Weng, J.-H.; Mori, Y.; Rogel, O.; Castle, S. L.; McAtee, J. J. Total Synthesis of the Teicoplanin Aglycon. J. Am. Chem. Soc. 2000, 122, 7416-7417.
16. (e) Boger, D. L.; Kim, S. H.; Mori, Y.; Weng, J.- H.; Rogel, O.; Castle, S. L.; McAtee, J. J. First and Second Generation Total Synthesis of the Teicoplanin Aglycon. J. Am. Chem. Soc. 2001, 123, 1862-1871.
17. (f) Crowley, B. M.; Mori, Y.; McComas, C. C.; Tang, D.; Boger, D. L. Total Synthesis of the Ristocetin Aglycon. J. Am. Chem. Soc. 2004, 126, 4310-4317.
18. (g) Boger, D. L. Vancomycin, Teicoplanin, and Ramoplanin: Synthetic and Mechanistic Studies. Med. Res. Rev. 2001, 21, 356-381.
19. Cristofaro, M. F.; Beauregard, D. A.; Yan, H.; Osborn, N. J.; Williams, D. H. Cooperativity between Non-Polar and Ionic Forces in the Binding of Bacterial Cell Wall Analogues by Vancomycin in Aqueous Solution. J. Antibiot. 1995, 48, 805-810.
20. (a) Booth, P. M.; Stone, D. J. M.; Williams, D. H. The Edman Degradation of Vancomycin: Preparation of Vancomycin Hexapeptide. J. Chem. Soc., Chem. Commun. 1987, 1694-1695. (b) Booth, P. M.; Williams, D. H. Preparation and Conformational Analysis of Vanco- mycin Hexapeptide and Aglucovancomycin Hexapeptide. J. Chem. Soc., Perkin Trans. 1 1989, 2335-2339.
21. (a) Gerber, P. R.; Muller, K. MAB, a Generally Applicable Molecular Force Field for Structure Modelling in Medicinal Chemistry. J. Com- put.-Aided Mol. Des 1995, 9, 251-268.
22. (b) Gerber Molecular Design. http://www.moloc.ch.
23. (c) Protein Databank (PDB code 1FVM), 1.8 A resolution. http://www.rcsb.org.
24. (d) Nitanai, Y.; Kikuchi, T.; Kakoi, K.; Hanamaki, S.; Fujisawa, I.; Aoki, K. Crystal Structures of the Complexes between Vancomycin and Cell-Wall Precursor Analogs. J. Mol. Biol., in press.
25. (a) All molecular graphics images were produced using the UCSF Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by Grant NIH P41 RR-01081). For details, see the following:
26. (b) Pettersen, E. F.; Goddard, T. D.; Huang, C. C.; Couch,G. S.; Greenblatt, D. M.; Meng, E. C.; Ferrin, T. E. UCSF Chimera-A Visualization System for Exploratory Research and Analysis. J. Com- put. Chem. 2004, 25, 1605-1612.
27. (c) Chimera home page can be found at http://www.cgl.ucsf.edu/chimera.
28. Kahne, D.; Walker, S.; Silva, D. J. Desleucyl Glycopeptide Antibiotics and Methods of Making Same. Patent WO 2000/59528 (US 2004110665), 2000.
29. Kim, S. J.; Matsuoka, S.; Patti, G. J.; Schaefer, J. Vancomycin Derivative with Damaged D-Ala-D-Ala Binding Cleft Binds to Cross- Linked Peptidoglycan in the Cell Wall of Staphylococcus aureus. Biochemistry 2008, 47, 3822-3831.
30. Hunt, A. H.; Marconi, G. G.; Elzey, T. K.; Hoehn, M. M. N- Demethylvancomycin. J. Antibiot. 1984, 37, 917-919.
31. Pavlov, A. Y.; Berdnikova, T. F.; Olsufyeva, E. N.; Lazhko, E. I.; Malkova, I. V.; Preobrazhenskaya, M. N. Synthesis and Biological Activity of Derivatives of Glycopeptide Antibiotics Eremomycin and Vancomycin Nitrosated, Acylated, or Carbamoylated at the N- Terminal. J. Antibiot. 1993, 46, 1731-1739.
32. Gale, T. F.; Gorlitzer, J.; O'Brien, S. W.; Williams, D. H. The Synthesis and Binding of N-Terminal Derivatives of Vancomycin to a Bacterial Cell Wall Analogue. J. Chem. Soc., Perkin Trans. 1 1999, 2267-2270.
33. Wanner, J.; Tang, D.; McComas, C. C.; Crowley, B. M.; Jiang, W.; Moss, J.; Boger, D. L. A New and Improved Method for Deglycosylation of Glycopeptide Antibiotics Exemplified with Vancomycin, Ristocetin, and Ramoplanin. Bioorg. Med. Chem. Lett. 2003, 13, 1169-1173.
34. Cheung, S. T.; Benoiton, N. L. N-Methylamino Acids in Peptide Synthesis. V. The Synthesis of N-tert-Butyloxycarbonyl,N-Methyl- amino Acids by N-methylation. Can. J. Chem. 1997, 55, 906-910.
35. Drake, B.; Patek, M.; Lebl, M. A Convenient Preparation of Mono- substituted N,N'-di(Boc)-Protected Guanidines. Synthesis 1994, 6, 579-582.
36. Armstrong, A.; Jones, L. H.; Knight, J. D.; Kelsey, R. D. Oxaziridine- Mediated Amination of Primary Amines: Scope and Application to a One-Pot Pyrazole Synthesis. Org. Lett. 2005, 7, 713-716.
37. Antimicrobial assays were run as previously described: (a) McComas, C. C.; Crowley, B. M.; Hwang, I.; Boger, D. L. Synthesis and Evaluation of Methyl Ether Derivatives of Vancomycin, Teicoplanin, and Ristocetin Aglycon Methyl Ethers. Bioorg. Med. Chem. Lett. 2003, 13, 2933-2936.
38. (b) McAtee, J. J.; Castle, S. L.; Jin, Q.; Boger, D. L. Synthesis and Evaluation of Vancomycin and Vancomycin Aglycon Analogues That Bear Modifications in the Residue 3 Asparagine. Bioorg. Med. Chem. Lett. 2002, 12, 1319-1322.
39. UV-difference titration assays were run as previously described:
40. (a) Nieto, M.; Perkins, H. R. The Specificity of Combination between Ristocetins and Peptides Related to Bacterial Cell Wall Mucopeptide Precursors. Biochem. J. 1971, 124, 845-852.
41. (b) Nieto, M.; Perkins, H. R. Physiochemical Properties of Vancomycin and Iodovancomycin and Their Complexes with Diacetyl-L-lysyl-D-alanyl-D-alanine. Bio- chem. J. 1971, 123, 773-787.
42. (c) Perkins, H. R. Specificity of Combination between Mucopeptide Precursors and Vancomycin or Ristocetin. Biochem. J. 1969, 111, 195-205.